Descemet Endothelial Thickness Comparison Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charles Lin, MD
Stanford University
Principal Investigator - Jennifer Rose-Nussbaumer, MD
University of California, San Francisco
Principal Investigator - Winston Chamberlain, MD, PhD
Oregon Health and Science University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Byers Eye Institute, Stanford University
Palo Alto, California, United States
- F. I. Proctor Foundation, University of California, San Francisco
San Francisco, California, United States
- Casey Eye Institute, Oregon Health & Science University
Portland, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Jan 2015
- Primary completion
- 4 Apr 2018
- Completion
- 30 May 2023
- Last update posted
- 25 Nov 2020
- Registered enrollment
- 38
- Registry id
- NCT02373137
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.